Literature DB >> 6192464

Nuclear magnetic resonance imaging of experimentally induced liver disease.

D D Stark, N M Bass, A A Moss, B R Bacon, J H McKerrow, C E Cann, A Brito, H I Goldberg.   

Abstract

Experimental animal models of hepatitis, fatty liver, and hepatic iron overload were evaluated using a 3.5-kGauss nuclear magnetic resonance (NMR) imaging system. Increases in image intensity measurements and in T2 relaxation times equalled the sensitivity of histologic findings for the detection of early stages of hepatitis. A significant shift in T1 relaxation times characterized the early stages of hepatic necrosis. Liver triglyceride content correlated significantly with increases in NMR intensity measurements (p less than 0.01); however, changes in liver water content had a much greater influence on intensity, T1, and T2. Thus, it may be possible to distinguish hepatitis from benign fatty liver. Liver iron content correlated with decreases in NMR intensity measurements (p less than 0.001), and iron levels as low as 1.2 mg/g were detected. NMR may more specifically identify hepatocellular iron overload than do other techniques that do not distinguish hepatocellular from reticuloendothelial iron.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192464     DOI: 10.1148/radiology.148.3.6192464

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  22 in total

Review 1.  Magnetic resonance imaging quantification of liver iron.

Authors:  Claude B Sirlin; Scott B Reeder
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

3.  Controlled aggregation of ferritin to modulate MRI relaxivity.

Authors:  Kevin M Bennett; Erik M Shapiro; Christopher H Sotak; Alan P Koretsky
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

4.  Hepatic iron overload: diagnosis and quantification by noninvasive imaging.

Authors:  J L Chezmar; R C Nelson; J A Malko; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1990

Review 5.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

6.  Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.

Authors:  Benjamin Leporq; Hélène Ratiney; Frank Pilleul; Olivier Beuf
Journal:  Eur Radiol       Date:  2013-04-16       Impact factor: 5.315

7.  Evaluation of focal hepatic masses: a comparative study of MRI and CT.

Authors:  G M Glazer; A M Aisen; I R Francis; B H Gross; J W Gyves; W D Ensminger
Journal:  Gastrointest Radiol       Date:  1986

Review 8.  Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases.

Authors:  John C Wood; Nilesh Ghugre
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

9.  Focal fatty liver change in a 12-year-old Japanese boy.

Authors:  M Igarashi; Y Akiyama; T Nakamura; S Ohtsuki; Y Nakashima
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

10.  Mimicking liver iron overload using liposomal ferritin preparations.

Authors:  John C Wood; Joe D Fassler; Tom Meade
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.